Perceptive Advisors Llc - Net Worth and Insider Trading

Perceptive Advisors Llc Net Worth

The estimated net worth of Perceptive Advisors Llc is at least $427 Million dollars as of 2024-05-04. Perceptive Advisors Llc is the 10% Owner of Amicus Therapeutics Inc and owns about 16,293,847 shares of Amicus Therapeutics Inc (FOLD) stock worth over $169 Million. Perceptive Advisors Llc is the 10% Owner of Repros Therapeutics Inc and owns about 2,862,560 shares of Repros Therapeutics Inc (RPRX) stock worth over $151 Million. Perceptive Advisors Llc is also the 10% Owner of Corium International Inc and owns about 5,546,129 shares of Corium International Inc (CORI) stock worth over $70 Million. Besides these, Perceptive Advisors Llc also holds Aegerion Pharmaceuticals Inc (AEGR) , Aldeyra Therapeutics Inc (ALDX) , Talphera Inc (TLPH) , VBI Vaccines Inc (VBIV) , Aravive Inc (ARAV) . Details can be seen in Perceptive Advisors Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Perceptive Advisors Llc has not made any transactions after 2017-05-25 and currently still holds the listed stock(s).

Transaction Summary of Perceptive Advisors Llc

Perceptive Advisors Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Perceptive Advisors Llc owns 44 companies in total, including ARYA Sciences Acquisition Corp II (ARYBU) , Athira Pharma Inc (ATHA) , and Quotient Ltd (QTNTQ) among others .

Click here to see the complete history of Perceptive Advisors Llc’s form 4 insider trades.

Insider Ownership Summary of Perceptive Advisors Llc

Ticker	Comapny	Transaction Date	Type of Owner
ARYBU	ARYA Sciences Acquisition Corp II	2020-10-20	director
ATHA	Athira Pharma Inc	2020-09-17	10 percent owner
QTNTQ	Quotient Ltd	2018-12-07	10 percent owner
		2019-05-03	10 percent owner
		2020-02-03	10 percent owner
		2020-07-09	10 percent owner
		2020-03-09	10 percent owner
		2018-01-25	director & 10 percent owner
		2020-03-09	10 percent owner
		2019-06-19	director & 10 percent owner
		2020-04-30	director & 10 percent owner
		2018-12-13	10 percent owner
		2020-04-17	10 percent owner
		2019-05-21	10 percent owner
		2019-03-04	10 percent owner
		2019-11-18	other: Former 10% owner
		2019-11-12	10 percent owner
		2019-07-29	10 percent owner
		2018-02-14	10 percent owner
		2018-09-12	10 percent owner
		2019-01-07	10 percent owner
		2018-10-11	10 percent owner
		2018-08-10	10 percent owner
		2018-06-14	10 percent owner
		2017-12-14	10 percent owner
		2017-09-21	10 percent owner
		2017-06-19	10 percent owner
		2013-09-05	10 percent owner
		2011-07-01	10 percent owner
		2008-01-03	10 percent owner
		2003-08-04	10 percent owner & other: Managing Member
		2004-02-06	10 percent owner
		2020-12-21	10 percent owner
		2021-01-28	director & 10 percent owner
		2021-10-07	10 percent owner
		2021-03-11	10 percent owner
		2021-04-22	10 percent owner
		2021-08-27	director & 10 percent owner
		2020-10-20	director
		2021-12-08	director
		2021-10-29	director & 10 percent owner
		2022-11-17	10 percent owner
		2023-04-04	10 percent owner
		2023-05-19	10 percent owner

Perceptive Advisors Llc Latest Holdings Summary

Perceptive Advisors Llc currently owns a total of 8 stocks. Among these stocks, Perceptive Advisors Llc owns 16,293,847 shares of Amicus Therapeutics Inc (FOLD) as of December 30, 2016, with a value of $169 Million and a weighting of 39.67%. Perceptive Advisors Llc owns 2,862,560 shares of Repros Therapeutics Inc (RPRX) as of May 14, 2012, with a value of $151 Million and a weighting of 35.36%. Perceptive Advisors Llc also owns 5,546,129 shares of Corium International Inc (CORI) as of May 25, 2017, with a value of $70 Million and a weighting of 16.47%. The other 5 stocks Aegerion Pharmaceuticals Inc (AEGR) , Aldeyra Therapeutics Inc (ALDX) , Talphera Inc (TLPH) , VBI Vaccines Inc (VBIV) , Aravive Inc (ARAV) have a combined weighting of 8.5% among all his current holdings.

Latest Holdings of Perceptive Advisors Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
FOLD	Amicus Therapeutics Inc	2016-12-30	16,293,847	10.40	169,456,009
RPRX	Repros Therapeutics Inc	2012-05-14	2,862,560	52.76	151,028,666
CORI	Corium International Inc	2017-05-25	5,546,129	12.68	70,324,916
AEGR	Aegerion Pharmaceuticals Inc	2013-09-05	12,743,704	1.97	25,105,097
ALDX	Aldeyra Therapeutics Inc	2017-02-14	2,589,451	4.16	10,772,116
TLPH	Talphera Inc	2016-09-29	269,321	1.02	274,707
VBIV	VBI Vaccines Inc	2016-12-06	207,110	0.59	122,195
ARAV	Aravive Inc	2017-02-13	704,762	0.04	28,261

Holding Weightings of Perceptive Advisors Llc

Perceptive Advisors Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Perceptive Advisors Llc has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the acquisition of 94,750 shares on December 30, 2016, which cost Perceptive Advisors Llc around $469,960.

According to the SEC Form 4 filings, Perceptive Advisors Llc has made a total of 0 transactions in Repros Therapeutics Inc (RPRX) over the past 5 years. The most-recent trade in Repros Therapeutics Inc is the acquisition of 59,500 shares on May 14, 2012, which cost Perceptive Advisors Llc around $439,110.

According to the SEC Form 4 filings, Perceptive Advisors Llc has made a total of 0 transactions in Corium International Inc (CORI) over the past 5 years. The most-recent trade in Corium International Inc is the acquisition of 1,902,400 shares on May 25, 2017, which cost Perceptive Advisors Llc around $12 Million.

More details on Perceptive Advisors Llc's insider transactions can be found in the Insider Trading History of Perceptive Advisors Llc table.

Insider Trading History of Perceptive Advisors Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Perceptive Advisors Llc Trading Performance

GuruFocus tracks the stock performance after each of Perceptive Advisors Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Perceptive Advisors Llc is 27.1%. GuruFocus also compares Perceptive Advisors Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Perceptive Advisors Llc within 3 months outperforms 32 times out of 43 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Perceptive Advisors Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Perceptive Advisors Llc

Average Return

Average return per transaction

Outperforming Transactions

26 out of 43 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	12.33
Relative Return to S&P 500(%)	10.93

Perceptive Advisors Llc Ownership Network

Ownership Network List of Perceptive Advisors Llc

No Data

Ownership Network Relation of Perceptive Advisors Llc

Perceptive Advisors Llc Owned Company Details

What does ARYA Sciences Acquisition Corp II do?

Who are the key executives at ARYA Sciences Acquisition Corp II?

Perceptive Advisors Llc is the director of ARYA Sciences Acquisition Corp II. Other key executives at ARYA Sciences Acquisition Corp II include director & Chief Executive Officer Adam Leo Stone , director & Chief Financial Officer Michael Seth Altman , and 10 percent owner Arya Sciences Holdings Ii .

ARYA Sciences Acquisition Corp II (ARYBU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp II (ARYBU)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYA Sciences Acquisition Corp II Insider Transactions

No Available Data

What does Athira Pharma Inc do?

Who are the key executives at Athira Pharma Inc?

Perceptive Advisors Llc is the 10 percent owner of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .

Athira Pharma Inc (ATHA) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Athira Pharma Inc (ATHA). Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,596 shares made by Andrew Gengos , a net sale of 9,640 shares made by Mark James Litton , and a net sale of 4,824 shares made by Rachel Lenington .

In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,528 shares of Athira Pharma Inc (ATHA) were sold and 800,698 shares were bought by its insiders, resulting in a net purchase of 774,170 shares.

Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Athira Pharma Inc Insider Transactions

No Available Data

What does Quotient Ltd do?

Who are the key executives at Quotient Ltd?

Perceptive Advisors Llc is the 10 percent owner of Quotient Ltd. Other key executives at Quotient Ltd include 10 percent owner Highbridge Capital Management Llc , 10 percent owner Quotient Holdings Finance Co Ltd , and 10 percent owner Quotient Holdings Newco, Lp .

Quotient Ltd (QTNTQ) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Quotient Ltd (QTNTQ). Other recent insider transactions involving Quotient Ltd (QTNTQ) include a net sale of 25,000 shares made by Prondzynski Heino Von , and a net sale of 1,014 shares made by Isabelle Buckle .

In summary, during the past 3 months, insiders sold 0 shares of Quotient Ltd (QTNTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,014 shares of Quotient Ltd (QTNTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 26,014 shares.

Quotient Ltd (QTNTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Quotient Ltd Insider Transactions

No Available Data

What does Athenex Inc do?

Who are the key executives at Athenex Inc?

Perceptive Advisors Llc is the 10 percent owner of Athenex Inc. Other key executives at Athenex Inc include director & CEO and Chairman of the Board Lau Johnson Yiu Nam , Chief Financial Officer Joe Annoni , and See Remarks Timothy Devere Cook .

Athenex Inc (ATNXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Athenex Inc (ATNXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Athenex Inc (ATNXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Athenex Inc (ATNXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Athenex Inc Insider Transactions

No Available Data

What does Albireo Pharma Inc do?

Who are the key executives at Albireo Pharma Inc?

Perceptive Advisors Llc is the 10 percent owner of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .

Albireo Pharma Inc (ALBO) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Albireo Pharma Inc (ALBO). Other recent insider transactions involving Albireo Pharma Inc (ALBO) include a net sale of 2,814 shares made by Pamela Stephenson , a net sale of 3,285 shares made by Jan Mattsson , and a net sale of 1,878 shares made by Harford Simon N.r. .

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,134 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,134 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Albireo Pharma Inc Insider Transactions

No Available Data

What does Aldeyra Therapeutics Inc do?

Who are the key executives at Aldeyra Therapeutics Inc?

Perceptive Advisors Llc is the 10 percent owner of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Development Officer Stephen Machatha , and director & President and CEO Todd C Brady .

Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 41,305 shares made by Stephen Machatha , and a net sale of 26,402 shares made by Bruce Greenberg .

In summary, during the past 3 months, insiders sold 250,945 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 682,265 shares, with a net purchase of 431,320 shares. During the past 18 months, 3,007,444 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,325,179 shares.

Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aldeyra Therapeutics Inc Insider Transactions

No Available Data

What does Leap Therapeutics Inc do?

Who are the key executives at Leap Therapeutics Inc?

Perceptive Advisors Llc is the 10 percent owner of Leap Therapeutics Inc. Other key executives at Leap Therapeutics Inc include Chief Scientific Officer Jason Baum , 10 percent owner Beigene, Ltd. , and VP & Head of Reg Affairs/Qual Christine Granfield .

Leap Therapeutics Inc (LPTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Leap Therapeutics Inc (LPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Leap Therapeutics Inc (LPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Leap Therapeutics Inc (LPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Leap Therapeutics Inc Insider Transactions

No Available Data

What does Solid Biosciences Inc do?

Who are the key executives at Solid Biosciences Inc?

Perceptive Advisors Llc is the director & 10 percent owner of Solid Biosciences Inc. Other key executives at Solid Biosciences Inc include director & Chief Executive Officer Ilan Ganot , director & 10 percent owner Ra Capital Healthcare Fund Lp , and director & 10 percent owner Perceptive Life Sciences Master Fund Ltd .

Solid Biosciences Inc (SLDB) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 3,291 shares made by Ilan Ganot , a net purchase of 3,410,713 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 904,160 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,771 shares of Solid Biosciences Inc (SLDB) were sold and 4,314,873 shares were bought by its insiders, resulting in a net purchase of 4,289,102 shares.

Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Solid Biosciences Inc Insider Transactions

No Available Data

What does VYNE Therapeutics Inc do?

Who are the key executives at VYNE Therapeutics Inc?

Perceptive Advisors Llc is the 10 percent owner of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .

VYNE Therapeutics Inc (VYNE) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 33,000 shares made by Patrick G Lepore , and a net purchase of 10,000 shares made by Mutya Harsch .

In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 43,000 shares were bought by its insiders, resulting in a net purchase of 43,000 shares.

VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

VYNE Therapeutics Inc Insider Transactions

No Available Data

What does MeiraGTx Holdings PLC do?

Who are the key executives at MeiraGTx Holdings PLC?

Perceptive Advisors Llc is the director & 10 percent owner of MeiraGTx Holdings PLC. Other key executives at MeiraGTx Holdings PLC include director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , 10 percent owner Johnson & Johnson , and 10 percent owner Johnson & Johnson Innovation - Jjdc, Inc. .

MeiraGTx Holdings PLC (MGTX) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in MeiraGTx Holdings PLC (MGTX). Other recent insider transactions involving MeiraGTx Holdings PLC (MGTX) include a net purchase of 4,347,826 shares made by Perceptive Life Sciences Master Fund Ltd ,

In summary, during the past 3 months, insiders sold 0 shares of MeiraGTx Holdings PLC (MGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MeiraGTx Holdings PLC (MGTX) were sold and 4,347,826 shares were bought by its insiders, resulting in a net purchase of 4,347,826 shares.

MeiraGTx Holdings PLC (MGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

MeiraGTx Holdings PLC Insider Transactions

No Available Data

What does Lyra Therapeutics Inc do?

Who are the key executives at Lyra Therapeutics Inc?

Perceptive Advisors Llc is the director & 10 percent owner of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Nbvm Gp, Llc , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .

Lyra Therapeutics Inc (LYRA) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 1,805,416 shares made by Nbvm Gp, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lyra Therapeutics Inc Insider Transactions

No Available Data

What does VBI Vaccines Inc do?

Who are the key executives at VBI Vaccines Inc?

Perceptive Advisors Llc is the 10 percent owner of VBI Vaccines Inc. Other key executives at VBI Vaccines Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Commercial Officer John Robert Dillman , and Director & Corp Development/IR Nell Beattie .

VBI Vaccines Inc (VBIV) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in VBI Vaccines Inc (VBIV). Other recent insider transactions involving VBI Vaccines Inc (VBIV) include a net sale of 10,894,749 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 609,090 shares made by Steven Gillis .

In summary, during the past 3 months, insiders sold 0 shares of VBI Vaccines Inc (VBIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 363,158 shares of VBI Vaccines Inc (VBIV) were sold and 609,090 shares were bought by its insiders, resulting in a net purchase of 245,932 shares.

VBI Vaccines Inc (VBIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

VBI Vaccines Inc Insider Transactions

No Available Data

What does Crinetics Pharmaceuticals Inc do?

Who are the key executives at Crinetics Pharmaceuticals Inc?

Perceptive Advisors Llc is the 10 percent owner of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Development Officer Dana Pizzuti , director & See Remarks Richard Scott Struthers , and Chief Operating Officer Jeff E. Knight .

Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Crinetics Pharmaceuticals Inc (CRNX). Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 38,966 shares made by Stephen F. Betz , a net sale of 61,634 shares made by Dana Pizzuti , and a net sale of 340,951 shares made by Richard Scott Struthers .

In summary, during the past 3 months, insiders sold 187,216 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 187,216 shares. During the past 18 months, 616,274 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 611,274 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Crinetics Pharmaceuticals Inc Insider Transactions

No Available Data

What does ADMA Biologics Inc do?

Who are the key executives at ADMA Biologics Inc?

Perceptive Advisors Llc is the 10 percent owner of ADMA Biologics Inc. Other key executives at ADMA Biologics Inc include director & President and CEO Adam S Grossman , EVP & CFO Brian Lenz , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .

ADMA Biologics Inc (ADMA) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 730,507 shares made by Adam S Grossman , a net sale of 1,500,000 shares made by Steve Elms , and a net sale of 382,769 shares made by Brian Lenz .

In summary, during the past 3 months, insiders sold 1,500,000 shares of ADMA Biologics Inc (ADMA) in total and bought 0 shares, with a net sale of 1,500,000 shares. During the past 18 months, 4,083,538 shares of ADMA Biologics Inc (ADMA) were sold and 191,958 shares were bought by its insiders, resulting in a net sale of 3,891,580 shares.

ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

ADMA Biologics Inc Insider Transactions

No Available Data

What does Agile Therapeutics Inc do?

Who are the key executives at Agile Therapeutics Inc?

Perceptive Advisors Llc is the 10 percent owner of Agile Therapeutics Inc. Other key executives at Agile Therapeutics Inc include Chief Financial Officer Scott M Coiante , Chief Commercial Officer Amy Welsh , and director & Chief Executive Officer Alfred Altomari .

Agile Therapeutics Inc (AGRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Agile Therapeutics Inc Insider Transactions

No Available Data

What does Kadmon Holdings Inc do?

Who are the key executives at Kadmon Holdings Inc?

Perceptive Advisors Llc is the other: Former 10% owner of Kadmon Holdings Inc. Other key executives at Kadmon Holdings Inc include director & President & CEO Harlan Waksal , Executive Vice President & CMO John L Ryan , and EVP & Chief Financial Officer Steven Meehan .

Kadmon Holdings Inc (KDMN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kadmon Holdings Inc (KDMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kadmon Holdings Inc (KDMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kadmon Holdings Inc (KDMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kadmon Holdings Inc Insider Transactions

No Available Data

What does Dova Pharmaceuticals Inc do?

Who are the key executives at Dova Pharmaceuticals Inc?

Perceptive Advisors Llc is the 10 percent owner of Dova Pharmaceuticals Inc. Other key executives at Dova Pharmaceuticals Inc include 10 percent owner Joseph Edelman , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Medical Officer Allen Lee F Md Phd .

Dova Pharmaceuticals Inc (DOVA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dova Pharmaceuticals Inc (DOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dova Pharmaceuticals Inc (DOVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dova Pharmaceuticals Inc (DOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dova Pharmaceuticals Inc Insider Transactions

No Available Data

What does Foamix Pharmaceuticals Ltd do?

Who are the key executives at Foamix Pharmaceuticals Ltd?

Perceptive Advisors Llc is the 10 percent owner of Foamix Pharmaceuticals Ltd. Other key executives at Foamix Pharmaceuticals Ltd include Chief Scientific Officer Iain Stuart , director & CEO David Domzalski , and CLO and General Counsel Mutya Harsch .

Foamix Pharmaceuticals Ltd (FOMX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Foamix Pharmaceuticals Ltd (FOMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foamix Pharmaceuticals Ltd (FOMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foamix Pharmaceuticals Ltd (FOMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Foamix Pharmaceuticals Ltd Insider Transactions

No Available Data

What does Motus GI Holdings Inc do?

Who are the key executives at Motus GI Holdings Inc?

Perceptive Advisors Llc is the 10 percent owner of Motus GI Holdings Inc. Other key executives at Motus GI Holdings Inc include 10 percent owner Orchestra Biomed Holdings, Inc. , Chief Financial Officer Ravit Ram , and Chief Accounting Officer Elad Amor .

Motus GI Holdings Inc (MOTS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Motus GI Holdings Inc (MOTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Motus GI Holdings Inc (MOTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Motus GI Holdings Inc (MOTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Motus GI Holdings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Perceptive Advisors Llc is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 634,200 shares made by John F Crowley , a net sale of 260,446 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .

In summary, during the past 3 months, insiders sold 145,222 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 145,222 shares. During the past 18 months, 1,232,982 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,232,982 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does La Jolla Pharmaceutical Co do?

Who are the key executives at La Jolla Pharmaceutical Co?

Perceptive Advisors Llc is the 10 percent owner of La Jolla Pharmaceutical Co. Other key executives at La Jolla Pharmaceutical Co include director & 10 percent owner Kevin C Tang , Chief Financial Officer Michael S Hearne , and director & Chief Executive Officer Larry G. Edwards .

La Jolla Pharmaceutical Co (LJPC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of La Jolla Pharmaceutical Co (LJPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of La Jolla Pharmaceutical Co (LJPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

La Jolla Pharmaceutical Co (LJPC)'s detailed insider trading history can be found in Insider Trading Tracker table.

La Jolla Pharmaceutical Co Insider Transactions

No Available Data

What does Corium International Inc do?

Who are the key executives at Corium International Inc?

Perceptive Advisors Llc is the 10 percent owner of Corium International Inc. Other key executives at Corium International Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .

Corium International Inc (CORI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Corium International Inc (CORI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corium International Inc (CORI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Corium International Inc (CORI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Corium International Inc Insider Transactions

No Available Data

What does Zogenix Inc do?

Who are the key executives at Zogenix Inc?

Perceptive Advisors Llc is the 10 percent owner of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .

Zogenix Inc (ZGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zogenix Inc Insider Transactions

No Available Data

What does Verrica Pharmaceuticals Inc do?

Who are the key executives at Verrica Pharmaceuticals Inc?

Perceptive Advisors Llc is the 10 percent owner of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , director & President and CEO Ted White , and Chief Commercial Officer Joe Bonaccorso .

Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Verrica Pharmaceuticals Inc (VRCA). Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net purchase of 2,060,199 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 84,376 shares made by Ted White , and a net sale of 71,108 shares made by Joe Bonaccorso .

In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 288,608 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,971,591 shares.

Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verrica Pharmaceuticals Inc Insider Transactions

No Available Data

What does Global Blood Therapeutics Inc do?

Who are the key executives at Global Blood Therapeutics Inc?

Perceptive Advisors Llc is the 10 percent owner of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .

Global Blood Therapeutics Inc (GBT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Global Blood Therapeutics Inc Insider Transactions

No Available Data

What does Aravive Inc do?

Who are the key executives at Aravive Inc?

Perceptive Advisors Llc is the 10 percent owner of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .

Aravive Inc (ARAV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aravive Inc Insider Transactions

No Available Data

What does Talphera Inc do?

Who are the key executives at Talphera Inc?

Perceptive Advisors Llc is the 10 percent owner of Talphera Inc. Other key executives at Talphera Inc include director & Chief Executive Officer Vincent J. Angotti , director & Chief Medical Officer Pamela P Palmer , and Chief Engineering Officer Badri N Dasu .

Talphera Inc (TLPH) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Talphera Inc (TLPH). Other recent insider transactions involving Talphera Inc (TLPH) include a net purchase of 20,000 shares made by Vincent J. Angotti , and a net sale of 16,956 shares made by Pamela P Palmer .

In summary, during the past 3 months, insiders sold 0 shares of Talphera Inc (TLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,956 shares of Talphera Inc (TLPH) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 3,044 shares.

Talphera Inc (TLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Talphera Inc Insider Transactions

No Available Data

What does Aegerion Pharmaceuticals Inc do?

Who are the key executives at Aegerion Pharmaceuticals Inc?

Perceptive Advisors Llc is the 10 percent owner of Aegerion Pharmaceuticals Inc. Other key executives at Aegerion Pharmaceuticals Inc include director & Chief Executive Officer Mary T Szela , other: See Remarks Gregory D Perry , and 10 percent owner Broadfin Healthcare Master Fund Ltd .

Aegerion Pharmaceuticals Inc (AEGR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aegerion Pharmaceuticals Inc (AEGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aegerion Pharmaceuticals Inc (AEGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aegerion Pharmaceuticals Inc (AEGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aegerion Pharmaceuticals Inc Insider Transactions

No Available Data

What does Heron Therapeutics Inc do?

Who are the key executives at Heron Therapeutics Inc?

Perceptive Advisors Llc is the 10 percent owner of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .

Heron Therapeutics Inc (HRTX) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .

In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.

Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Heron Therapeutics Inc Insider Transactions

No Available Data

What does XTL Biopharmaceuticals Ltd do?

Who are the key executives at XTL Biopharmaceuticals Ltd?

Perceptive Advisors Llc is the 10 percent owner of XTL Biopharmaceuticals Ltd. Other key executives at XTL Biopharmaceuticals Ltd include 10 percent owner Joseph Edelman , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and 10 percent owner Michael Cho .

XTL Biopharmaceuticals Ltd (XTLB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of XTL Biopharmaceuticals Ltd (XTLB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XTL Biopharmaceuticals Ltd (XTLB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XTL Biopharmaceuticals Ltd (XTLB)'s detailed insider trading history can be found in Insider Trading Tracker table.

XTL Biopharmaceuticals Ltd Insider Transactions

No Available Data

What does ANI Pharmaceuticals Inc do?

Who are the key executives at ANI Pharmaceuticals Inc?

Perceptive Advisors Llc is the 10 percent owner & other: Managing Member of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include SVP - CORP. DEV. & STRATEGY Chad Gassert , director & HEAD OF R&D & COO-NOVITIUM OPS Muthusamy Shanmugam , and SR. VP & GENERAL COUNSEL & SEC. Meredith Cook .

ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 626,190 shares made by Muthusamy Shanmugam , a net sale of 160,000 shares made by Chad Gassert , and a net sale of 1,500 shares made by Meredith Cook .

In summary, during the past 3 months, insiders sold 250,132 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 250,132 shares. During the past 18 months, 1,391,108 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,391,108 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

ANI Pharmaceuticals Inc Insider Transactions

No Available Data

What does Antares Pharma Inc do?

Who are the key executives at Antares Pharma Inc?

Perceptive Advisors Llc is the 10 percent owner of Antares Pharma Inc. Other key executives at Antares Pharma Inc include See Remarks Peter C Richardson , Executive Vice President & CFO Fred M Powell , and See Remarks Peter J Graham .

Antares Pharma Inc (ATRS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Antares Pharma Inc Insider Transactions

No Available Data

What does SCYNEXIS Inc do?

Who are the key executives at SCYNEXIS Inc?

Perceptive Advisors Llc is the 10 percent owner of SCYNEXIS Inc. Other key executives at SCYNEXIS Inc include Chief Financial Officer Ivor Macleod , General Counsel Scott Sukenick , and Interim CFO Lawrence R Hoffman .

SCYNEXIS Inc (SCYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of SCYNEXIS Inc (SCYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SCYNEXIS Inc (SCYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SCYNEXIS Inc (SCYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

SCYNEXIS Inc Insider Transactions

No Available Data

What does Astria Therapeutics Inc do?

Who are the key executives at Astria Therapeutics Inc?

Perceptive Advisors Llc is the director & 10 percent owner of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .

Astria Therapeutics Inc (ATXS) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 5,204,223 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .

In summary, during the past 3 months, insiders sold 10,000 shares of Astria Therapeutics Inc (ATXS) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 5,204,223 shares were bought by its insiders, resulting in a net purchase of 5,184,223 shares.

Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Astria Therapeutics Inc Insider Transactions

No Available Data

What does IsoPlexis Corp do?

Who are the key executives at IsoPlexis Corp?

Perceptive Advisors Llc is the 10 percent owner of IsoPlexis Corp. Other key executives at IsoPlexis Corp include Chief Financial Officer John Strahley , SVP & GC & Secretary Rew Richard W. Ii , and director & Chief Executive Officer Sean Mackay .

IsoPlexis Corp (ISO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of IsoPlexis Corp (ISO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IsoPlexis Corp (ISO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

IsoPlexis Corp (ISO)'s detailed insider trading history can be found in Insider Trading Tracker table.

IsoPlexis Corp Insider Transactions

No Available Data

What does Prometheus Biosciences Inc do?

Who are the key executives at Prometheus Biosciences Inc?

Perceptive Advisors Llc is the 10 percent owner of Prometheus Biosciences Inc. Other key executives at Prometheus Biosciences Inc include Chief Financial Officer Keith W Marshall , director & President and CEO Mark C. Mckenna , and 10 percent owner Cedars Sinai Intellectual Property Co .

Prometheus Biosciences Inc (RXDX) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Prometheus Biosciences Inc (RXDX). Other recent insider transactions involving Prometheus Biosciences Inc (RXDX) include a net sale of 125,000 shares made by Mark C. Mckenna , a net sale of 30,000 shares made by Keith W Marshall , and a net sale of 865,000 shares made by Cedars Sinai Intellectual Property Co .

In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,020,000 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,020,000 shares.

Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Prometheus Biosciences Inc Insider Transactions

No Available Data

What does Rain Oncology Inc do?

Who are the key executives at Rain Oncology Inc?

Perceptive Advisors Llc is the 10 percent owner of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Management Llc .

Rain Oncology Inc (RAIN) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , a net purchase of 164,881 shares made by Franklin M Berger , and a net purchase of 1,710,358 shares made by Biotechnology Value Fund L P .

In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 3,247,657 shares were bought by its insiders, resulting in a net purchase of 2,078,684 shares.

Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rain Oncology Inc Insider Transactions

No Available Data

What does Landos Biopharma Inc do?

Who are the key executives at Landos Biopharma Inc?

Perceptive Advisors Llc is the director & 10 percent owner of Landos Biopharma Inc. Other key executives at Landos Biopharma Inc include 10 percent owner Perceptive Xontogeny Venture Fund Ii, Lp , 10 percent owner Roderick Wong , and 10 percent owner Rtw Investments, Lp .

Landos Biopharma Inc (LABP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Landos Biopharma Inc (LABP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Landos Biopharma Inc (LABP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Landos Biopharma Inc (LABP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Landos Biopharma Inc Insider Transactions

No Available Data

What does Cerevel Therapeutics Holdings Inc do?

Who are the key executives at Cerevel Therapeutics Holdings Inc?

Perceptive Advisors Llc is the director of Cerevel Therapeutics Holdings Inc. Other key executives at Cerevel Therapeutics Holdings Inc include director & See Remarks N Anthony Coles , Chief Scientific Officer John Renger , and Chief Medical Officer Ramiro Sanchez .

Cerevel Therapeutics Holdings Inc (CERE) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Cerevel Therapeutics Holdings Inc (CERE). Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 802,506 shares made by N Anthony Coles , a net sale of 37,652 shares made by Ramiro Sanchez , and a net sale of 24,572 shares made by Scott Akamine .

In summary, during the past 3 months, insiders sold 154,667 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 0 shares, with a net sale of 154,667 shares. During the past 18 months, 1,141,157 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 17,422,701 shares were bought by its insiders, resulting in a net purchase of 16,281,544 shares.

Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cerevel Therapeutics Holdings Inc Insider Transactions

No Available Data

What does Nautilus Biotechnology Inc do?

Who are the key executives at Nautilus Biotechnology Inc?

Perceptive Advisors Llc is the director of Nautilus Biotechnology Inc. Other key executives at Nautilus Biotechnology Inc include director & 10 percent owner & CEO & President & and Secretary Sujal M Patel , Senior VP & Product Development Subramanian Sankar , and Chief People Officer Gwen E Weld .

Nautilus Biotechnology Inc (NAUT) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Nautilus Biotechnology Inc (NAUT). Other recent insider transactions involving Nautilus Biotechnology Inc (NAUT) include a net purchase of 50,000 shares made by Sujal M Patel ,

In summary, during the past 3 months, insiders sold 0 shares of Nautilus Biotechnology Inc (NAUT) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 0 shares of Nautilus Biotechnology Inc (NAUT) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 50,000 shares.

Nautilus Biotechnology Inc (NAUT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nautilus Biotechnology Inc Insider Transactions

No Available Data

What does LianBio do?

Who are the key executives at LianBio?

Perceptive Advisors Llc is the director & 10 percent owner of LianBio. Other key executives at LianBio include 10 percent owner Perceptive Life Sciences Master Fund Ltd , 10 percent owner Joseph Edelman , and Chief Financial Officer Yi Larson .

LianBio (LIANY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of LianBio (LIANY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LianBio (LIANY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

LianBio (LIANY)'s detailed insider trading history can be found in Insider Trading Tracker table.

LianBio Insider Transactions

No Available Data

What does Acrivon Therapeutics Inc do?

Who are the key executives at Acrivon Therapeutics Inc?

Perceptive Advisors Llc is the 10 percent owner of Acrivon Therapeutics Inc. Other key executives at Acrivon Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Legal Officer Mary Miller , and director & President and CEO Peter Blume-jensen .

Acrivon Therapeutics Inc (ACRV) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Acrivon Therapeutics Inc (ACRV). Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net purchase of 392,035 shares made by Chione Ltd , a net purchase of 3,389,500 shares made by Ra Capital Healthcare Fund Lp , and a net purchase of 2,353,000 shares made by Perceptive Life Sciences Master Fund Ltd .

In summary, during the past 3 months, insiders sold 0 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 2,353,000 shares, with a net purchase of 2,353,000 shares. During the past 18 months, 7,965 shares of Acrivon Therapeutics Inc (ACRV) were sold and 6,142,500 shares were bought by its insiders, resulting in a net purchase of 6,134,535 shares.

Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Acrivon Therapeutics Inc Insider Transactions

No Available Data

What does Chembio Diagnostics Inc do?

Who are the key executives at Chembio Diagnostics Inc?

Perceptive Advisors Llc is the 10 percent owner of Chembio Diagnostics Inc. Other key executives at Chembio Diagnostics Inc include 10 percent owner Perceptive Credit Advisors, Llc , 10 percent owner Joseph Edelman , and See remarks Paul Angelico .

Chembio Diagnostics Inc (CEMI) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Chembio Diagnostics Inc (CEMI). Other recent insider transactions involving Chembio Diagnostics Inc (CEMI) include a net purchase of 1,490,120 shares made by Perceptive Credit Advisors, Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Chembio Diagnostics Inc (CEMI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chembio Diagnostics Inc (CEMI) were sold and 1,490,120 shares were bought by its insiders, resulting in a net purchase of 1,490,120 shares.

Chembio Diagnostics Inc (CEMI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chembio Diagnostics Inc Insider Transactions

No Available Data

What does Soleno Therapeutics Inc do?

Who are the key executives at Soleno Therapeutics Inc?

Perceptive Advisors Llc is the 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include 10 percent owner Vivo Opportunity Fund Holdings, L.p. , See Remarks Patricia C Hirano , and See Remarks Kristen Yen .

Soleno Therapeutics Inc (SLNO) Insider Trades Summary

Over the past 18 months, Perceptive Advisors Llc made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net purchase of 1,210,087 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 196,136 shares made by Bhatnagar Anish , and a net sale of 52,057 shares made by Kristen Yen .

In summary, during the past 3 months, insiders sold 1,129,833 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 1,129,833 shares. During the past 18 months, 1,849,928 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net sale of 639,841 shares.

Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Soleno Therapeutics Inc Insider Transactions

No Available Data

Perceptive Advisors Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Perceptive Advisors Llc. You might contact Perceptive Advisors Llc via mailing address: 51 Astor Place, 10th Floor, New York Ny 10003.

Discussions on Perceptive Advisors Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.